DexCom
0.56 %
-27.05 %
Yet to be announced
Company Overview
DexCom, Inc. is a medical device company that develops, manufactures, and distributes continuous glucose monitoring (CGM) systems for diabetes management. The company's primary products are FDA-approved devices that provide real-time glucose readings throughout the day and night, enabling better diabetes management for patients. Their flagship product line includes the G6 and G7 CGM systems, which help patients make informed decisions about their diabetes care.
Revenue Sources
PassBased on review of DexCom's SEC filings and financial statements, the company generates its revenue primarily from the sale of continuous glucose monitoring systems and related supplies. These products serve a clear medical purpose and are not haram. There is no evidence of revenue from prohibited sources such as alcohol, tobacco, gambling, or other haram activities.
Reliance on Interest
| Reporting Date | Total Revenue | Total Expense | Interest Income | Interest Expense | Interest Income Ratio | Interest Expense Ratio |
|---|---|---|---|---|---|---|
| March 31, 2025 | $1.04b | $902.3m | - | - | 0.00% | 0.00% |
| Dec. 31, 2024 | $1.11b | $924.6m | - | - | 0.00% | 0.00% |
| Sept. 30, 2024 | $994.2m | $842.2m | - | - | 0.00% | 0.00% |
| June 30, 2024 | $1.0b | $846.3m | - | - | 0.00% | 0.00% |
Analysis of DexCom's financial statements for the past four quarters shows no interest income or interest expense. The company appears to operate without significant reliance on interest-bearing debt or interest-generating investments. This indicates that interest does not play a material role in the company's business model.
Operational Ethics
PassBased on review of DexCom's public disclosures, operations, and facilities locations, there is no evidence of significant ongoing associations with entities involved in human rights violations. The company's primary operations and manufacturing facilities are located in the United States and the Philippines, with no indication of material ties to the state of Israel or the Chinese Communist Party.
Comments